EGFR and colorectal cancer: UDCA is cytoprotective against secondary BAs such as DCA and has been previously shown to be able to inhibit DCA-induced activation of the EGFR/Raf-1/ERK signaling pathway in HCT-116 cells and in an azoxymethane mouse model for colorectal cancer [20, 21].